532 related articles for article (PubMed ID: 17557314)
41. Evaluation of hepatic iron overload in Chinese children with β-thalassemia major.
Xu LH; Fang JP; Xu HG; Weng WJ
Pediatr Hematol Oncol; 2011 Nov; 28(8):702-7. PubMed ID: 21970505
[TBL] [Abstract][Full Text] [Related]
42. Effect of HCV infection on hepatic fibrosis in patients of thalassaemia major.
Anwar M; Nadeem A; Jamal S; Dilawar M; Ali W; Aziz S; Ayyub M; Ahmed P; Ashraf T; Khan B; Hussain T; Hussain S;
J Coll Physicians Surg Pak; 2006 Mar; 16(3):200-3. PubMed ID: 16542600
[TBL] [Abstract][Full Text] [Related]
43. Pituitary iron and volume predict hypogonadism in transfusional iron overload.
Noetzli LJ; Panigrahy A; Mittelman SD; Hyderi A; Dongelyan A; Coates TD; Wood JC
Am J Hematol; 2012 Feb; 87(2):167-71. PubMed ID: 22213195
[TBL] [Abstract][Full Text] [Related]
44. The investigation of gingival iron accumulation in thalassemia major patients.
Calişkan U; Tonguç MO; Ciriş M; Balta N; Kirzioglu FY; Caglayan G; Canatan D
J Pediatr Hematol Oncol; 2011 Mar; 33(2):98-102. PubMed ID: 21285897
[TBL] [Abstract][Full Text] [Related]
45. Severe iron overload in Blackfan-Diamond anemia: a case-control study.
Roggero S; Quarello P; Vinciguerra T; Longo F; Piga A; Ramenghi U
Am J Hematol; 2009 Nov; 84(11):729-32. PubMed ID: 19810012
[TBL] [Abstract][Full Text] [Related]
46. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
[TBL] [Abstract][Full Text] [Related]
47. Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation.
McKay PJ; Murphy JA; Cameron S; Burnett AK; Campbell M; Tansey P; Franklin IM
Bone Marrow Transplant; 1996 Jan; 17(1):63-6. PubMed ID: 8673057
[TBL] [Abstract][Full Text] [Related]
48. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
[TBL] [Abstract][Full Text] [Related]
49. Synergic effect of chronic hepatitis C infection and beta thalassemia major with marked hepatic iron overload on liver fibrosis: a retrospective cross-sectional study.
Ardalan FA; Osquei MR; Toosi MN; Irvanloo G
BMC Gastroenterol; 2004 Aug; 4():17. PubMed ID: 15307893
[TBL] [Abstract][Full Text] [Related]
50. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.
Fung EB; Harmatz P; Milet M; Ballas SK; De Castro L; Hagar W; Owen W; Olivieri N; Smith-Whitley K; Darbari D; Wang W; Vichinsky E;
Am J Hematol; 2007 Apr; 82(4):255-65. PubMed ID: 17094096
[TBL] [Abstract][Full Text] [Related]
51. Iron overload and chronically transfused patients: numbers, scales, and clinical research.
Callea F
Am J Hematol; 2009 Aug; 84(8):471-2. PubMed ID: 19565648
[No Abstract] [Full Text] [Related]
52. Iron overload following bone marrow transplantation in children: MR findings.
Kornreich L; Horev G; Yaniv I; Stein J; Grunebaum M; Zaizov R
Pediatr Radiol; 1997 Nov; 27(11):869-72. PubMed ID: 9361048
[TBL] [Abstract][Full Text] [Related]
53. Real-life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET.
Vitrano A; Calvaruso G; Tesé L; Gioia F; Cassarà F; Campisi S; Butera F; Commendatore V; Rizzo M; Santoro V; Cigna V; Quota A; Bagnato S; Argento C; Fidone C; Schembari D; Gerardi C; Barbiera F; Bellisssima G; Giugno G; Polizzi G; Rosso R; Abbate G; Caruso V; Chiodi E; Gamberini MR; Giorgi B; Putti MC; Filosa A; De Ritis MR; Oliva E; Arcadi N; Fustaneo M; Mistretta L; Di Maggio R; Sacco M; Veronica DS; Giangreco A; Maggio A
Eur J Haematol; 2016 Oct; 97(4):361-70. PubMed ID: 26818147
[TBL] [Abstract][Full Text] [Related]
54. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
[TBL] [Abstract][Full Text] [Related]
55. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
[TBL] [Abstract][Full Text] [Related]
56. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease.
Fung EB; Harmatz PR; Lee PD; Milet M; Bellevue R; Jeng MR; Kalinyak KA; Hudes M; Bhatia S; Vichinsky EP;
Br J Haematol; 2006 Nov; 135(4):574-82. PubMed ID: 17054676
[TBL] [Abstract][Full Text] [Related]
57. Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and Chelation.
Stanley HM; Friedman DF; Webb J; Kwiatkowski JL
Pediatr Blood Cancer; 2016 Aug; 63(8):1414-8. PubMed ID: 27100139
[TBL] [Abstract][Full Text] [Related]
58. Gender differences in the prevalence and severity of bone disease in thalassaemia.
Kyriakou A; Savva SC; Savvides I; Pangalou E; Ioannou YS; Christou S; Skordis N
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
[TBL] [Abstract][Full Text] [Related]
59. Iron removal in ex-thalassemics after BMT: preliminary results from the phlebotomy program. Italian Cooperative Group for Phlebotomy in Ex-thalassemic.
Angelucci E; Baronciani D; Giardini C; Argiolu F; Becchelli G; Borgna Pignatti C; Campisi S; Careddu F; Conter V; De Nunzio A
Bone Marrow Transplant; 1993; 12 Suppl 1():105. PubMed ID: 8374546
[No Abstract] [Full Text] [Related]
60. Chronically transfused pediatric sickle cell patients are protected from cardiac iron overload.
Kaushik N; Eckrich MJ; Parra D; Yang E
Pediatr Hematol Oncol; 2012 Apr; 29(3):254-60. PubMed ID: 22303979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]